Rachaniotis Nikolaos P, Dasaklis Thomas K, Fotopoulos Filippos, Chouzouris Michalis, Sypsa Vana, Lyberaki Antigone, Tinios Platon
Department of Industrial Management and Technology, University of Piraeus, 18534 Piraeus, Greece.
School of Social Sciences, Hellenic Open University, 26335 Patras, Greece.
Vaccines (Basel). 2022 Feb 18;10(2):329. doi: 10.3390/vaccines10020329.
Vaccine hesitancy, which potentially leads to the refusal or delayed acceptance of COVID-19 vaccines, is considered a key driver of the increasing death toll from the pandemic in the EU. The European Commission and several member states' governments are either planning or have already directly or indirectly announced mandatory vaccination for individuals aged over 60, the group which has repeatedly proved to be the most vulnerable. In this paper, an assessment of this strategy's benefits is attempted by deriving a metric for the potential gains of vaccination mandates that can be used to compare EU member states. This is completed by examining the reduction in Standard Expected Years of Life Lost (SEYLL) per person for the EU population over 60 as a function of the member states' vaccination percentage in these ages. The publicly available data and results of the second iteration of the SHARE COVID-19 survey on the acceptance of COVID-19 vaccines, conducted during the summer of 2021, are used as inputs.
疫苗犹豫,即可能导致拒绝或延迟接种新冠疫苗,被认为是欧盟大流行死亡人数增加的关键驱动因素。欧盟委员会和几个成员国政府要么正在计划,要么已经直接或间接宣布对60岁以上人群强制接种疫苗,该群体一再被证明是最脆弱的群体。在本文中,试图通过推导一个可用于比较欧盟成员国的疫苗强制接种潜在收益指标,来评估这一策略的益处。这是通过将60岁以上欧盟人口每人的标准预期寿命损失年数(SEYLL)的减少量作为这些年龄段成员国疫苗接种率的函数来完成的。2021年夏季进行的关于新冠疫苗接受情况的SHARE COVID-19调查第二轮的公开可用数据和结果被用作输入。